参考文献/References:
[1] Wasserstein AG.Membranous glomerulonephritis[J].J Am Soc Nephro,1997,8(4):664-674.
[2] Segal PE,Choi MJ.Recent advances and prognosis in idiopathic membranous nephropathy[J].Adv Chronic Kidney Dis,2012,19(2):114-119.
[3] Yang L,Liu D,Liu Z,et al.Recent advances and prognosis in membranous nephropathy[J].Chinese Journal of Nephrology,2016,32(3):229-232.
[4] 王海燕.肾脏病学[M].3版.北京:人民卫生出版社,2008:1032-1042.
[5] Beck LH Jr,Bonegio RG,Lambeau G,et al.M-type phospholipase A2 receptor as target antigen in idiopathic membranous nephmpathy.N Engl J Med,2009,361(1):11-21.
[6] Qin W,Beck LH Jr,Zeng C,et al.Anti-phospholipase A2 receptor antibody in membranous nephropathy.J Am Soc Nephrol,2011,22(11):1137-1143.
[7] 邹万忠.肾活检病理学[M].北京:北京大学医学出版社,2009:156-162.
[8] 贾利敏.不典型膜性肾病患者血栓弹力图与常规凝血试验相关性分析[J].陕西医学杂志,2018,47(12):1528-1531.
[9] Prunotto M,Carnevali ML,Candiano G,et al.Autoimmunity in membranous nephropathy targets aldose reductase and SOD2[J].J Am Soc Nephrol,2010,21:507-519.
[10] Glassock RJ.The pathogenesis of idiopathic membranous nephropathy:a 50-year odyssey[J].Am J Kidney Dis,2010,56(1):157-167.
[11] 张 翥,丁庆龙,李炳辰.继发性膜性肾病的病因与治疗[J].中国临床医生杂志,2019,47(9):1014-1016.
[12] Larsen CP,Messias NC,Silva FG,et al.Determination of primary versus secondary membranous glomerulopathy utilizing phospholipase A2 receptor staining in renal biopsies[J].Mod Pathol,2013,26(5):709-715.
[13] Hofstra JM,Beck LH Jr,Beck DM,et al.Anti-phospholipase A2 receptor antibodies correlate with clinical status in idiopathic membraneous nephropathy[J].Clin J Am Soc Nephrol,2011,6(6):1286-1291.
[14] Zhang R,Zheng ZY,Lin JS,et al.The continual presence of C3d but not IgG glomerular capillary deposition in stage Ⅰ idiopathic membranous nephropathy in patients receiving corticosteroid treatment[J].Diagnostic Pathology,2012,7:109.
[15] 周广宇,金 玲,于 晶,等.成人膜性肾病患者血清抗PLA2R抗体与病情的相关性[J].中华肾脏病杂志,2012,28(2):111-114.
[16] Huang CC,Lehman A,Albawardi A,et al.IgG subclass staining in renal biopsies with membranous glomerulonephritis indicates subclass switch during disease progression[J].Mod Pathol,2013,26(6):799-805.
[17] Du Y,Li J,He F,et al.The diagnosis accuracy of PLA2R-AB in the diagnosis of idiopathic membranous nephropathy:a meta-analysis[J].PLoS One,2014,9(8):e104936.
[18] Oh YJ,Yang SH,Kim DK,et al.Autoantibodies against phospholipase A2 receptor in Korean patients with membranous nephropathy[J].PLos One,2013,8(4):65-65.
[19] Beck LH Jr,Salant DJ.Membranous nephropathy:recent travels and new roads ahead [J].Kidney Int,2010,77(9):765-770.
[20] 曹鹏龙,李士军,郐婷婷,等.血清抗M型磷酯酶A2受体抗体与成人特发性膜性肾病的相关性[J].实用医学杂志,2014,30(15):2441-2444.
[21] 刘莎莎,桑晓红,刘 珍.特发性膜性肾病诊断及治疗研究进展[J].中华实用诊断与治疗杂志,2017,31(1):82-84.
[22] 董鸿瑞,王艳艳,王国勤,等.检测特发性膜性肾病肾小球IgG亚型沉积及磷脂酶A2受体表达的回顾性分析[J].中国实用内科杂志,2014,34(5):507-511.
[23] 祝爽爽,周树录,周朝敏,等.成人特发性膜性肾病肾组织M型磷脂酶A2受体1抗原的检测[J].南方医科大学报,2015,35(4):526-529.
[24] Nicola MV,Sede SM,Pozner R,et al.Phylogeography and palaeodistribution modelling of Nassauvia subgenus strongyloma(asteraceae):exploring phylogeographical scenarios in the Patagonian steppe[J].Ecology and Evolution,2014,4(22):4270-4286.
[25] 王爱春,沙文刚.特发性膜性肾病与M 型磷脂酶A2受体[J].中国中西医结合肾病杂志,2014,15(1):78-79.
[26] De Vriese AS,Glassock RJ,Nath KA,et al.A proposal for a serology-based approach to membranous nephropathy[J].J Am Soc Nephrol,2017,28(2):421-430.
[27] 曲逸伦,董哲毅,陈香美.膜性肾病诊断方式的演变[J].解放军医学杂志,2019,44(12):1067-1071.